STOCKWATCH
·
Specialty Chemicals
Quarterly Result2 May 2026, 04:11 pm

Epigral Ltd Q4FY26: Revenue Up 17% to ₹736 Cr, Dividend ₹5

AI Summary

Epigral Ltd reported a record Q4FY26 revenue of ₹736 crore, a 17% increase from ₹631 crore in Q4FY25. Profit After Tax (PAT) stood at ₹82 crore. The Board proposed a final dividend of ₹5 per equity share. Revenue grew by 22% sequentially, driven by improved volumes and realizations. EBITDA margin improved to 23% from 17% in Q3FY26. The company's capex projects for Epichlorohydrin and CPVC expansion are progressing as planned.

Key Highlights

  • Q4FY26 revenue reached a record ₹736 crore, up 17% year-on-year.
  • The board proposed a final dividend of ₹5 per share for FY26.
  • EBITDA margin improved to 23% in Q4FY26 from 17% in Q3FY26.
  • Capex projects for Epichlorohydrin and CPVC expansion are on track.
  • FY26 revenue stood at ₹2,542 Crore, a 1% drop due to lower sales volume.
MFL
Specialty Chemicals
Meghmani Finechem Ltd

Price Impact